The global endoscopic ultrasound needles market is expected to grow at a CAGR of 4.6% from 2022 to 2028. The market is segmented by region into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America is the largest market for endoscopic ultrasound needles, accounting for a share of over 35% in 2022. This is due to the high prevalence of cancer and gastrointestinal disorders in the region, as well as the availability of advanced healthcare facilities. The United States is the leading country in the North American market, followed by Canada.

Europe is the second-largest market for endoscopic ultrasound needles, accounting for a share slightly lesser than that of North America. This is due to the aging population in the region, as well as the increasing incidence of cancer and gastrointestinal disorders. Germany, France, and Italy are the leading countries in the European market.

Asia Pacific is the fastest-growing market for endoscopic ultrasound needles, accounting for a share slightly lesser than that of Europe. This is due to the increasing aging population, the high prevalence of cancer and gastrointestinal disorders, and the growing number of testing labs for endoscopy in the region. China, Japan, and India are the leading countries in the Asia-Pacific market.

Latin America and Middle East & Africa are the smaller markets for endoscopic ultrasound needles, but they are expected to grow at a faster pace than the other regions during the forecast period. This is due to the increasing awareness of the benefits of EUS procedures in these regions.

Key Players

The key players in the global endoscopic ultrasound needles market include Cook Medical, Olympus, Boston Scientific, CONMED, and Medtronic. These companies are developing innovative products and expanding their product portfolios to meet the growing demand for endoscopic ultrasound needles in the global market.

Conclusion

The global endoscopic ultrasound needles market is expected to grow at a healthy CAGR during the forecast period. The market is being driven by the increasing prevalence of cancer, the increasing number of diseases that require EUS procedures, and the growing geriatric population. The Asia Pacific market is expected to grow at the fastest pace during the forecast period.